2-{[(6-chloropyridin-3-yl)methyl]sulfanyl}-6-methyl-4-(trifluoromethyl)pyridine-3-carbonitrile

Catalog No. :
ACMNFQ631
CAS No. :
674805-54-0
Molecular Formula :
C14H9ClF3N3S
Molecular Weight :
343.76

IUPAC Name:2-(((6-chloropyridin-3-yl)methyl)thio)-6-methyl-4-(trifluoromethyl)nicotinonitrile

2-{[(6-chloropyridin-3-yl)methyl]sulfanyl}-6-methyl-4-(trifluoromethyl)pyridine-3-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$214.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-{[(6-chloropyridin-3-yl)methyl]sulfanyl}-6-methyl-4-(trifluoromethyl)pyridine-3-carbonitrile
IUPAC Name2-(((6-chloropyridin-3-yl)methyl)thio)-6-methyl-4-(trifluoromethyl)nicotinonitrile
MDL No.MFCD03863404
Molecular FormulaC14H9ClF3N3S
Molecular Weight343.76
SMILESN#CC1=C(C(F)(F)F)C=C(C)N=C1SCC2=CC=C(Cl)N=C2
InChI KeyGNFUZYQLUOCFAV-UHFFFAOYSA-N
Synonym2-{[(6-chloro-3-pyridinyl)methyl]sulfanyl}-6-methyl-4-(trifluoromethyl)nicotinonitrile
CAS No.674805-54-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACMNFQ631 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMNFQ631 route product structure diagram
    ACMNFQ631674805-54-0
Inquiry

2. ACMNFQ631 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNIWU831 route compound structure diagram
    ACNIWU83113600-48-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMNFQ631 route product structure diagram
    ACMNFQ631674805-54-0
Inquiry

Comments (0)